Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1975 1
1977 2
1989 1
1999 1
2000 1
2002 2
2004 2
2005 1
2007 2
2008 6
2009 1
2011 2
2012 4
2014 2
2015 3
2016 4
2017 3
2018 4
2019 6
2020 3
2021 4
2022 3
2023 1
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
Fatigue and cognitive impairment after COVID-19: A prospective multicentre study.
Hartung TJ, Neumann C, Bahmer T, Chaplinskaya-Sobol I, Endres M, Geritz J, Haeusler KG, Heuschmann PU, Hildesheim H, Hinz A, Hopff S, Horn A, Krawczak M, Krist L, Kudelka J, Lieb W, Maetzler C, Mehnert-Theuerkauf A, Montellano FA, Morbach C, Schmidt S, Schreiber S, Steigerwald F, Störk S, Maetzler W, Finke C. Hartung TJ, et al. Among authors: steigerwald f. EClinicalMedicine. 2022 Sep 17;53:101651. doi: 10.1016/j.eclinm.2022.101651. eCollection 2022 Nov. EClinicalMedicine. 2022. PMID: 36133318 Free PMC article.
Directional Deep Brain Stimulation.
Steigerwald F, Matthies C, Volkmann J. Steigerwald F, et al. Neurotherapeutics. 2019 Jan;16(1):100-104. doi: 10.1007/s13311-018-0667-7. Neurotherapeutics. 2019. PMID: 30232718 Free PMC article. Review.
Predictors of non-recovery from fatigue and cognitive deficits after COVID-19: a prospective, longitudinal, population-based study.
Hartung TJ, Bahmer T, Chaplinskaya-Sobol I, Deckert J, Endres M, Franzpötter K, Geritz J, Haeusler KG, Hein G, Heuschmann PU, Hopff SM, Horn A, Keil T, Krawczak M, Krist L, Lieb W, Maetzler C, Montellano FA, Morbach C, Neumann C, Nürnberger C, Russ AK, Schmidbauer L, Schmidt S, Schreiber S, Steigerwald F, Störk S, Zoller T, Maetzler W, Finke C; NAPKON Study Group. Hartung TJ, et al. Among authors: steigerwald f. EClinicalMedicine. 2024 Feb 3;69:102456. doi: 10.1016/j.eclinm.2024.102456. eCollection 2024 Mar. EClinicalMedicine. 2024. PMID: 38333368 Free PMC article.
Intensive heart rhythm monitoring to decrease ischemic stroke and systemic embolism-the Find-AF 2 study-rationale and design.
Uhe T, Wasser K, Weber-Krüger M, Schäbitz WR, Köhrmann M, Brachmann J, Laufs U, Dichgans M, Gelbrich G, Petroff D, Prettin C, Michalski D, Kraft A, Etgen T, Schellinger PD, Soda H, Bethke F, Ertl M, Kallmünzer B, Grond M, Althaus K, Hamann GF, Mende M, Wagner M, Gröschel S, Uphaus T, Gröschel K, Wachter R; Find-AF 2 study group. Uhe T, et al. Am Heart J. 2023 Nov;265:66-76. doi: 10.1016/j.ahj.2023.06.016. Epub 2023 Jul 7. Am Heart J. 2023. PMID: 37422010 Free article. Clinical Trial.
Directional leads for deep brain stimulation: Opportunities and challenges.
Schüpbach WMM, Chabardes S, Matthies C, Pollo C, Steigerwald F, Timmermann L, Visser Vandewalle V, Volkmann J, Schuurman PR. Schüpbach WMM, et al. Among authors: steigerwald f. Mov Disord. 2017 Oct;32(10):1371-1375. doi: 10.1002/mds.27096. Epub 2017 Aug 26. Mov Disord. 2017. PMID: 28843016 Free article. Review. No abstract available.
Smell and taste in idiopathic blepharospasm.
Gamain J, Herr T, Fleischmann R, Stenner A, Vollmer M, Willert C, Veit B, Lehnert B, Mueller JU, Steigerwald F, Tost F, Kronenbuerger M. Gamain J, et al. Among authors: steigerwald f. J Neural Transm (Vienna). 2021 Aug;128(8):1215-1224. doi: 10.1007/s00702-021-02366-4. Epub 2021 Jun 28. J Neural Transm (Vienna). 2021. PMID: 34184129 Free PMC article.
Immediate-release/extended-release amantadine (OS320) to treat Parkinson's disease with levodopa-induced dyskinesia: Analysis of the randomized, controlled ALLAY-LID studies.
Rascol O, Tönges L, deVries T, Jaros M, Quartel A, Jacobs D; ALLAY-LID I and ALLAY-LID II study groups. Rascol O, et al. Parkinsonism Relat Disord. 2022 Mar;96:65-73. doi: 10.1016/j.parkreldis.2022.01.022. Epub 2022 Feb 8. Parkinsonism Relat Disord. 2022. PMID: 35227940 Free article. Clinical Trial.
Retinal changes in Parkinson's disease and glaucoma.
Matlach J, Wagner M, Malzahn U, Schmidtmann I, Steigerwald F, Musacchio T, Volkmann J, Grehn F, Göbel W, Klebe S. Matlach J, et al. Among authors: steigerwald f. Parkinsonism Relat Disord. 2018 Nov;56:41-46. doi: 10.1016/j.parkreldis.2018.06.016. Epub 2018 Jun 21. Parkinsonism Relat Disord. 2018. PMID: 29937099
Pulse duration settings in subthalamic stimulation for Parkinson's disease.
Steigerwald F, Timmermann L, Kühn A, Schnitzler A, Reich MM, Kirsch AD, Barbe MT, Visser-Vandewalle V, Hübl J, van Riesen C, Groiss SJ, Moldovan AS, Lin S, Carcieri S, Manola L, Volkmann J. Steigerwald F, et al. Mov Disord. 2018 Jan;33(1):165-169. doi: 10.1002/mds.27238. Epub 2017 Nov 22. Mov Disord. 2018. PMID: 29165837 Free PMC article. Clinical Trial.
57 results